Evaluation of an innovative mobile health programme for the self-management of chronic obstructive pulmonary disease (MH-COPD): protocol of a randomised controlled trial

Ding, Hang; Karunanithi, Mohanraj; Ireland, Derek; McCarthy, Lisa; Hakim, Rekha; Phillips, Kirsten; Pradhan, Rahul; Seah, E.; Bowman, Rayleen V.; Fong, Kwun M.; Masel, P.; Yang, Ian A.

doi:10.1136/bmjopen-2018-025381

Cited by 16 publications

(22 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Virtual reality technology and rehabilitation may be the way of the future with this technology currently being evaluated in the United Kingdom for ease of use and acceptability by people with COPD (53). Finally, the rapidly expanding world of e-health and mobile applications is being examined in the United Kingdom using the myPR application (54), and in Australia using the MH-COPD application (55). Both Australian and New Zealand researchers are developing mobile pulmonary rehabilitation applications which will feature text messaging support and enable patients to complete a pulmonary rehabilitation program directly from a smartphone (56,57).…”

Section: Strategies To Improve 'Engagement' With Pulmonary Rehabilita...mentioning

confidence: 99%

Innovative strategies to improve the reach and engagement in pulmonary rehabilitation

2019

View full text Add to dashboard Cite

Evidence of personal and health-system benefits of pulmonary rehabilitation are undeniable.However, the capacity of traditional centre-based models to both reach and appeal to the intended population of people living with chronic obstructive pulmonary disease (COPD) remains difficult. It is well established that issues with access, suitability, referral, uptake, and attrition exist. Consequently, considerable energy has been invested into exploring innovative alternative modes of rehabilitation in an effort to increase the awareness and appeal, and expand the availability of pulmonary rehabilitation. The process of 'thinking differently' and 'pushing the boundaries' of clinical practice is underway, particularly in the United Kingdom and Australia, where new models of pulmonary rehabilitation are being evaluated. The number one priority is reaching the population of people with COPD and ensuring they are referred to rehabilitation services.Active case-finding in primary care, inviting health professionals and health consumers to pulmonary rehabilitation programs to increase understanding and awareness, and utilizing peer support via patient success stories, are just a few suggestions for increasing awareness of pulmonary rehabilitation. Once referred, engaging the population to complete a program is the next challenge. Marketing, patient co-design, alternative rehabilitation settings and modes of exercise training, use of technology, and focusing on modes which provide patient enjoyment and choice are all potential strategies to target in an effort to broaden the appeal and reduce the high attrition rate of traditional centre-based pulmonary rehabilitation programs. Reaching and engaging the target population in pulmonary rehabilitation is an important first step in people with COPD achieving successful outcomes from rehabilitation.

show abstract

Section: Strategies To Improve 'Engagement' With Pulmonary Rehabilita...mentioning

confidence: 99%

Innovative strategies to improve the reach and engagement in pulmonary rehabilitation

2019

View full text Add to dashboard Cite

show abstract

“…From selected studies 16 articles related to patients with COPD, 5 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 three articles related to asthmatic patients, 18 , 38 , 39 six articles about cancer patients, 3 , 40 , 41 and lung transplantation 42 , 43 , 44 and one related to cystic fibrosis (CF) 45 and the last to patients with acute respiratory diseases. 46 The frequency of studies according to respiratory disorders is shown in Figure 2 .…”

Section: Resultsmentioning

confidence: 99%

“…According to the results of the present study, collecting and sending patients' respiratory symptoms to physicians through m‐Health apps leads to improving symptoms of the disease. 3 , 18 , 23 , 25 , 38 , 39 , 40 , 47 …”

Section: Resultsmentioning

confidence: 99%

Evaluation of m‐Health‐rehabilitation for respiratory disorders: A systematic review

Kiani

Abasi

Yazdani

2022

Health Science Reports

View full text Add to dashboard Cite

Background and Aims Chronic respiratory diseases are prominent causes of morbidity worldwide that impose significant social and economic burdens on individuals and communities. Pulmonary rehabilitation is one of the main aspects of medical rehabilitation. Nowadays, mobile health apps deliver pulmonary rehabilitation support via smartphones. This article presents a systematic review of the literature on m‐Health apps used in respiration disorders rehabilitation. Methods A systematic search was performed on MEDLINE (through PubMed), Web of Science, and Scopus in May 2021 without any date limitation. This study was using a combination of keywords and MeSH terms associated with pulmonary rehabilitation. Relevant studies were selected by two independents and were categorized studies results. The inclusion criterion was m‐Health apps for pulmonary rehabilitation and exclusion criteria mobile‐based interventions, by voice call or short message service and cardiopulmonary articles. Results Searching scientific databases yielded 161 relevant articles. Then, 27 articles were included in the study with a complete evaluation of the articles. Sixty percent of them were related to patients with chronic obstructive pulmonary disease (COPD). Rehabilitation aiming to improve the quality of life, promote self‐management, encourage physical activity, and reduce the symptoms as the most common goals of pulmonary rehabilitation using m‐Health apps; 89% of these studies showed that m‐Health apps can be effective in improving pulmonary rehabilitation. In addition, 37% of studies reported high usability and acceptance. However, the results of some studies show that adherence to apps decreases in the long run. Conclusion Our study shows that m‐Health pulmonary rehabilitation apps are effective in improving the quality of life, self‐management, and physical activity. According to the results, it seems that using the m‐Health apps for pulmonary rehabilitation can be useful in the COVID‐19 pandemic and help reduce respiratory disorders in patients with COVID‐19 disease.

show abstract

“…With regard to these determinants of use, it is worth mentioning that the patients who participated in our study were motivated in their self-care because of frequent decompensations of their disease, with hospitalization for COPD occurring in more than half of the patients evaluated. There is evidence that participants will tolerate the burden of diary-keeping if they feel it will help them [47,48]. In this regard, it should be mentioned that the Prevexair app sent messages about healthy lifestyle behaviors and information about the patient's medication, task notifications, and a record of their cumulative symptoms in a graph through the app, which has been found to have a compliance advantage.…”

Section: Interpretation Of Novel Findingsmentioning

confidence: 99%

Compliance and Utility of a Smartphone App for the Detection of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease: Cohort Study

Hermosa¹,

Gomila²,

Diago³

et al. 2020

JMIR Mhealth Uhealth

View full text Add to dashboard Cite

Background In recent years, mobile health (mHealth)–related apps have been developed to help manage chronic diseases. Apps may allow patients with a chronic disease characterized by exacerbations, such as chronic obstructive pulmonary disease (COPD), to track and even suspect disease exacerbations, thereby facilitating self-management and prompt intervention. Nevertheless, there is insufficient evidence regarding patient compliance in the daily use of mHealth apps for chronic disease monitoring. Objective This study aimed to provide further evidence in support of prospectively recording daily symptoms as a useful strategy to detect COPD exacerbations through the smartphone app, Prevexair. It also aimed to analyze daily compliance and the frequency and characteristics of acute exacerbations of COPD recorded using Prevexair. Methods This is a multicenter cohort study with prospective case recruitment including 116 patients with COPD who had a documented history of frequent exacerbations and were monitored over the course of 6 months. At recruitment, the Prevexair app was installed on their smartphones, and patients were instructed on how to use the app. The information recorded in the app included symptom changes, use of medication, and use of health care resources. The patients received messages on healthy lifestyle behaviors and a record of their cumulative symptoms in the app. There was no regular contact with the research team and no mentoring process. An exacerbation was considered reported if medical attention was sought and considered unreported if it was not reported to a health care professional. Results Overall, compliance with daily records in the app was 66.6% (120/180), with a duration compliance of 78.8%, which was similar across disease severity, age, and comorbidity variables. However, patients who were active smokers, with greater dyspnea and a diagnosis of depression and obesity had lower compliance (P<.05). During the study, the patients experienced a total of 262 exacerbations according to daily records in the app, 99 (37.8%) of which were reported exacerbations and 163 (62.2%) were unreported exacerbations. None of the subject-related variables were found to be significantly associated with reporting. The duration of the event and number of symptoms present during the first day were strongly associated with reporting. Despite substantial variations in the COPD Assessment Test (CAT), there was improvement only among patients with no exacerbation and those with reported exacerbations. Nevertheless, CAT scores deteriorated among patients with unreported exacerbations. Conclusions The daily use of the Prevexair app is feasible and acceptable for patients with COPD who are motivated in their self-care because of frequent exacerbations of their disease. Monitoring through the Prevexair app showed great potential for the implementation of self-care plans and offered a better diagnosis of their chronic condition.

show abstract

Evaluation of an innovative mobile health programme for the self-management of chronic obstructive pulmonary disease (MH-COPD): protocol of a randomised controlled trial

Cited by 16 publications

References 39 publications

Innovative strategies to improve the reach and engagement in pulmonary rehabilitation

Innovative strategies to improve the reach and engagement in pulmonary rehabilitation

Evaluation of m‐Health‐rehabilitation for respiratory disorders: A systematic review

Compliance and Utility of a Smartphone App for the Detection of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease: Cohort Study

Contact Info

Product

Resources

About